OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.770
0.00 (0.00%)
Nov 5, 2026, 10:56 AM EST - Market open
OPKO Health Revenue
OPKO Health had revenue of $130.83M in the quarter ending September 30, 2026, a decrease of -13.74%. This brings the company's total for the last twelve months to $715.60M, up 11.45% year-over-year. In the year 2025, OPKO Health had annual revenue of $1.21B with 70.20% growth. That makes OPKO Health the 10,352nd largest company in the world by revenue and 2,190th in the United States.
Revenue (ttm)
$715.60M
Revenue Growth
+11.45%
P/S Ratio
2.02
Revenue / Employee
$287,515
Employees
2,275
Market Cap
1.32B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full OPKO Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.21B | 500.66M | 70.20% |
| Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
| Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
| Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
| Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
| Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
| Dec 31, 2019 | 901.94M | -88.33M | -8.92% |
| Dec 31, 2018 | 990.27M | 24.26M | 2.51% |
| Dec 31, 2017 | 966.01M | -255.66M | -20.93% |
| Dec 31, 2016 | 1.22B | 729.92M | 148.44% |
| Dec 31, 2015 | 491.74M | 400.61M | 439.63% |
| Dec 31, 2014 | 91.13M | -5.41M | -5.60% |
| Dec 31, 2013 | 96.53M | 49.49M | 105.19% |
| Dec 31, 2012 | 47.04M | 19.07M | 68.14% |
| Dec 31, 2011 | 27.98M | -515.00K | -1.81% |
| Dec 31, 2010 | 28.49M | 24.08M | 544.95% |
| Dec 31, 2009 | 4.42M | -5.02M | -53.20% |
| Dec 31, 2008 | 9.44M | 8.59M | 1,014.52% |
| Dec 31, 2007 | 847.00K | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sotera Health Company | 1.23B |
| Myriad Genetics | 806.60M |
| NeoGenomics | 787.75M |
| Veracyte | 561.90M |
| CareDx | 497.40M |
| GeneDx Holdings | 454.43M |
| Castle Biosciences | 357.28M |
| Fulgent Genetics | 323.93M |
OPK News
- 17 hours ago - Opko Health reports Q3 EPS (7c), consensus (6c) - TheFly
- 17 hours ago - Opko Health sees Q4 revenue $62M-$72M - TheFly
- 17 hours ago - Opko Health sees FY26 revenue $268M-$278M - TheFly
- 18 hours ago - OPKO Health Earnings Call Transcript: Q3 2026 - Transcripts
- 18 hours ago - OPKO Health Earnings release: Q3 2026 - Filings
- 18 hours ago - OPKO Health Quarterly report: Q3 2026 - Filings
- 18 hours ago - OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results - GlobeNewsWire
- 8 days ago - OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026 - GlobeNewsWire